7-octadecynoic acid

7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid

MeSH term MeSH ID Detail
Uremia D014511 33 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Diarrhea D003967 32 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Neoplasms, Experimental D009374 10 associated lipids
Hypercalcemia D006934 13 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Adenocarcinoma D000230 166 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Per page 10 20 50 100 | Total 298

All references with 7-octadecynoic acid

Download all related citations
Per page 10 20 50 100 | Total 4091
Authors Title Published Journal PubMed Link
Zang L et al. The effects of lung and prostate cancer bone metastasis on serum osteoprotegerin levels: a meta-analysis. 2015 Sci Rep pmid:26671549
Kato G et al. The inhibitory effects of a RANKL-binding peptide on articular and periarticular bone loss in a murine model of collagen-induced arthritis: a bone histomorphometric study. 2015 Arthritis Res. Ther. pmid:26373710
Li CW et al. Opg/Rankl mRNA dynamic expression in the bone tissue of ovariectomized rats with osteoporosis. 2015 Genet. Mol. Res. pmid:26345854
Pan X et al. Association of TRAIL and Its Receptors with Large-Artery Atherosclerotic Stroke. 2015 PLoS ONE pmid:26334877
Wang B et al. Chondrocytes-Specific Expression of Osteoprotegerin Modulates Osteoclast Formation in Metaphyseal Bone. 2015 Sci Rep pmid:26329493
Fernández-González FJ et al. Experimental evidence of pharmacological management of anchorage in Orthodontics: A systematic review. 2015 Dental Press J Orthod pmid:26560822
Burton LJ et al. Muscadine grape skin extract can antagonize Snail-cathepsin L-mediated invasion, migration and osteoclastogenesis in prostate and breast cancer cells. 2015 Carcinogenesis pmid:26069256
Collins FL et al. Death Receptor 3 (TNFRSF25) Increases Mineral Apposition by Osteoblasts and Region Specific New Bone Formation in the Axial Skeleton of Male DBA/1 Mice. 2015 J Immunol Res pmid:26065008
Zavala-Cerna MG et al. Osteoprotegerin Polymorphisms in a Mexican Population with Rheumatoid Arthritis and Generalized Osteoporosis: A Preliminary Report. 2015 J Immunol Res pmid:26065000
Zheng Y et al. Mesenchymal dental pulp cells attenuate dentin resorption in homeostasis. 2015 J. Dent. Res. pmid:25762594
Tsuruda T Osteoprotegerin: osteo-vascular connection. 2015 J. Atheroscler. Thromb. pmid:25740050
Shah M et al. Local origins impart conserved bone type-related differences in human osteoblast behaviour. 2015 Eur Cell Mater pmid:25738584
Estanislau IM et al. Pleiotropic effects of statins on the treatment of chronic periodontitis--a systematic review. 2015 Br J Clin Pharmacol pmid:25444240
Esteghamati A et al. Association of osteoprotegerin with peripheral artery disease in patients with type 2 diabetes. 2015 Aug-Sep Arch Cardiovasc Dis pmid:26184866
SaÄŸlam M et al. Effect of sumac extract on serum oxidative status, RANKL/OPG system and alveolar bone loss in experimental periodontitis in rats. 2015 Jan-Feb J Appl Oral Sci pmid:25760266
Sasso GR et al. Elevated serum osteoprotegerin levels in women: friend or foe? 2015 Nov-Dec Rev Assoc Med Bras (1992) pmid:26841162
Calasans-Maia MD et al. Cytocompatibility and biocompatibility of nanostructured carbonated hydroxyapatite spheres for bone repair. 2015 Nov-Dec J Appl Oral Sci pmid:26814461
Jianru YI et al. Static compression regulates OPG expression in periodontal ligament cells via the CAMK II pathway. 2015 Nov-Dec J Appl Oral Sci pmid:26814456
Kose O et al. Influences of Fucoxanthin on Alveolar Bone Resorption in Induced Periodontitis in Rat Molars. 2016 Mar Drugs pmid:27043583
Shah AP et al. Effects of Minocycline on Urine Albumin, Interleukin-6, and Osteoprotegerin in Patients with Diabetic Nephropathy: A Randomized Controlled Pilot Trial. 2016 PLoS ONE pmid:27019421
Dela Cruz A et al. Elevated Gα11 expression in osteoblast lineage cells promotes osteoclastogenesis and leads to enhanced trabecular bone accrual in response to pamidronate. 2016 Am. J. Physiol. Endocrinol. Metab. pmid:27006198
Lis GJ et al. Influence of osteoclasts and osteoprotegerin on the mode of calcific degeneration of aortic valves. 2016 Pol. Arch. Med. Wewn. pmid:27003233
Tsuruda T et al. Angiotensin II Stimulation of Cardiac Hypertrophy and Functional Decompensation in Osteoprotegerin-Deficient Mice. 2016 Hypertension pmid:27001297
Kats A et al. Aminothiazoles inhibit RANKL- and LPS-mediated osteoclastogenesis and PGE2 production in RAW 264.7 cells. 2016 J. Cell. Mol. Med. pmid:26987561
Moran CS et al. Modulation of Kinin B2 Receptor Signaling Controls Aortic Dilatation and Rupture in the Angiotensin II-Infused Apolipoprotein E-Deficient Mouse. 2016 Arterioscler. Thromb. Vasc. Biol. pmid:26966276
Cong Q et al. p38α MAPK Regulates Lineage Commitment and OPG Synthesis of Bone Marrow Stromal Cells to Prevent Bone Loss under Physiological and Pathological Conditions. 2016 Stem Cell Reports pmid:26947973
Wang C et al. Adenovirus-mediated siRNA targeting CXCR2 attenuates titanium particle-induced osteolysis by suppressing osteoclast formation. 2016 Med. Sci. Monit. pmid:26939934
Lin J et al. Increased generation of Foxp3(+) regulatory T cells by manipulating antigen presentation in the thymus. 2016 Nat Commun pmid:26923114
Li N et al. Calycosin attenuates osteoporosis and regulates the expression of OPG/RANKL in ovariectomized rats MAPK signaling. 2016 Pharmazie pmid:29441931
Yuan SY et al. Puerarin prevents bone loss in ovariectomized mice and inhibits osteoclast formation in vitro. 2016 Chin J Nat Med pmid:27114313
Davaine JM et al. Bone Like Arterial Calcification in Femoral Atherosclerotic Lesions: Prevalence and Role of Osteoprotegerin and Pericytes. 2016 Eur J Vasc Endovasc Surg pmid:26652270
Li J et al. Effect of gallium nitrate on the expression of osteoprotegerin and receptor activator of nuclear factor‑κB ligand in osteoblasts in vivo and in vitro. 2016 Mol Med Rep pmid:26647856
Cervellati C et al. Higher Urinary Levels of 8-Hydroxy-2'-deoxyguanosine Are Associated with a Worse RANKL/OPG Ratio in Postmenopausal Women with Osteopenia. 2016 Oxid Med Cell Longev pmid:26635910
Alam I et al. Osteoblast-Specific Overexpression of Human WNT16 Increases Both Cortical and Trabecular Bone Mass and Structure in Mice. 2016 Endocrinology pmid:26584014
Zhao N et al. Isolation and Functional Analysis of an Immortalized Murine Cementocyte Cell Line, IDG-CM6. 2016 J. Bone Miner. Res. pmid:26274352
Liu YD et al. Systemic administration of strontium or NBD peptide ameliorates early stage cartilage degradation of mouse mandibular condyles. 2016 Osteoarthr. Cartil. pmid:26256766
Liu G et al. Endoplasmic reticulum stress-mediated inflammatory signaling pathways within the osteolytic periosteum and interface membrane in particle-induced osteolysis. 2016 Cell Tissue Res. pmid:26004143
Wang S et al. Anti-inflammatory and anti-arthritic effects of taraxasterol on adjuvant-induced arthritis in rats. 2016 J Ethnopharmacol pmid:27109342
Bergamini A et al. Expression of the receptor activator of nuclear factor-kB ligand in peripheral blood mononuclear cells in patients with acute Charcot neuroarthropathy. 2016 Int J Med Sci pmid:28090190
O'Sullivan S et al. Tyrosine Kinase Inhibitors Regulate OPG through Inhibition of PDGFRβ. 2016 PLoS ONE pmid:27737004
Li M et al. Heparan Sulfate Regulates the Structure and Function of Osteoprotegerin in Osteoclastogenesis. 2016 J. Biol. Chem. pmid:27697839
Shirakawa J and Kulkarni RN Novel factors modulating human β-cell proliferation. 2016 Diabetes Obes Metab pmid:27615134
Xing R et al. Interleukin-21 promotes osteoclastogenesis in RAW264.7 cells through the PI3K/AKT signaling pathway independently of RANKL. 2016 Int. J. Mol. Med. pmid:27599586
Yongdi L et al. [Osteoprotegerin/receptor activator of nuclear factor-κB ligand expression in mandibular distraction osteogenesis regulated by parathyroid hormone]. 2016 Hua Xi Kou Qiang Yi Xue Za Zhi pmid:27526445
Qian H et al. FSH aggravates bone loss in ovariectomised rats with experimental periapical periodontitis. 2016 Mol Med Rep pmid:27510616
Røysland R et al. Diagnostic and Prognostic Properties of Osteoprotegerin in Patients with Acute Dyspnoea: Observations from the Akershus Cardiac Examination (ACE) 2 Study. 2016 PLoS ONE pmid:27463973
Piemontese M et al. Cortical bone loss caused by glucocorticoid excess requires RANKL production by osteocytes and is associated with reduced OPG expression in mice. 2016 Am. J. Physiol. Endocrinol. Metab. pmid:27460899
Zhao JJ et al. MicroRNA-145 Mediates Steroid-Induced Necrosis of the Femoral Head by Targeting the OPG/RANK/RANKL Signaling Pathway. 2016 PLoS ONE pmid:27459539
Ugay L et al. Role of Osteoprotegerin and Receptor Activator of Nuclear Factor-κB Ligand in Bone Loss Related to Advanced Chronic Obstructive Pulmonary Disease. 2016 Chin. Med. J. pmid:27411457
Pellegrini GG et al. Avenanthramides Prevent Osteoblast and Osteocyte Apoptosis and Induce Osteoclast Apoptosis in Vitro in an Nrf2-Independent Manner. 2016 Nutrients pmid:27409635

Table of Content